Cure My Disease

Don't miss your cure!

 Log in / Sign up

New nerve block aimed at cutting opioid use after bypass

NCT ID NCT07587320

Symptom relief Sponsor: Saglik Bilimleri Universitesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving a set of nerve blocks (injections of numbing medicine) right after anesthesia but before surgery can reduce pain and the need for opioid painkillers after coronary artery bypass grafting. 56 adults scheduled for elective bypass surgery will be randomly assigned to receive either the nerve blocks plus standard pain care, or standard care alone. The main goal is to measure total opioid use in the first 48 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nerve block package (ultrasound-guided injections of local anesthetic)
What this could lead to
If it works, this could offer a better way to manage pain after heart bypass surgery, reducing the need for strong painkillers like opioids.
What could go wrong
This is a small, early-phase study (56 people) testing a procedure, not a drug. The nerve blocks may not provide significant extra pain relief, and there are small risks like bleeding or infection at the injection sites.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 56 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age between 18 and 80 years * Scheduled for elective isolated coronary artery bypass grafting (CABG) with saphenous vein graft harvesting * ASA physical status II-IV * Ability to provide written informed consent Exclusion Criteria: * Known coagulopathy or contraindication to regional anesthesia * Use of anticoagulant therapy precluding regional block * Known allergy to local anesthetics * Local infection at planned block sites * Chronic opioid use or chronic pain syndrome * Emergency surgery * Redo sternotomy * Severe neurological disorder affecting pain assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery bypass graft (CABG) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery bypass graft (CABG) Postoperative pain Sternotomy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Health Sciences, Diyarbakir Gazi Yasargil Training and Research Hospital

    RECRUITING

    Diyarbakır, Diyarbakır, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.